Brand awareness, consumer satisfaction, and market perception all play a big role in a company’s success. Even the death of a key company player can affect a company’s bottom line. In Apple’s case, the death of Steve Jobs, one of the Apple Inc. cofounders, brings more awareness to the company. The death of Jobs hit [...]
On September 16, 2011, President Obama signed the America Invents Act (AIA). The AIA has been legislated for the past six years and marks the first major change in patent reform for the past sixty years. Although the AIA covers different areas of patent prosecution and patent litigation, this article will focus on the AIA’s [...]
For many athletes, there is nothing like Gatorade to quench thirst after a hard workout. For women with high hopes of becoming mothers, a tool to increase in vitro fertilization success may make their dreams come true. For Crohn’s disease sufferers, Remicade may be the only drug that provides them relief. For inquiring minds, Google [...]
Controversy over the country’s debt ceiling and Standard & Poor’s downgrade of the debt has caused a stir around the world. From aggressive stock market changes to interest rate hikes, consumers fear the worst. While nobody really knows the true effects of what the debt issues will mean, many fear more economic woes and trouble [...]
Chemotherapy drugs have several purposes. Doctors use chemotherapy drugs to treat cancer, control cancer symptoms, and make cancer more sensitive to radiotherapy. Cancer patients desperately need chemotherapy drugs. During the past year, U.S. hospitals have reported a generic chemotherapy drug shortage. According to Supply Chain Matters, 99.5% of hospitals experienced at least one drug shortage [...]
Generic alternatives are available for practically any ailment a person can get. So, why would consumers buy anything but generics? After all, the active ingredients are identical to the brand name version, and the price is typically 80% cheaper on average than a brand name drug.
7/15/2011 Welcome to our new Blog section where we will discuss many issues related to IP Valuation and other industry concerns. Please check back often to read our new articles.
